Foundation Venture, affiliated with New Jersey Health Foundation, announces backing for life sciences research firm MentiNova.

Foundation Venture Capital Group, a New Jersey Health Foundation affiliate that invests exclusively in research at the University of Medicine and Dentistry of New Jersey (UMDNJ) by funding new life science companies, has backed MentiNova, which is exploring an oral medication that could reduce side-effects to treatments to Parkinson’s disease.  Foundation has committed up to…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.